Abstract:A clinically comparable multi-tasking computerized deep U-Net-based model is demonstrated in this paper. It intends to offer clinical gland morphometric information and cancer grade classification to be provided as referential opinions for pathologists in order to abate human errors. It embraces enhanced feature learning capability that aids in extraction of potent multi-scale features; efficacious semantic gap recovery during feature concatenation; and successful interception of resolution-degradation and vanishing gradient problems while performing moderate computations. It is proposed by integrating three unique novel structural components namely Hybrid Convolutional Learning Units in the encoder and decoder, Attention Learning Units in skip connection, and Multi-Scalar Dilated Transitional Unit as the transitional layer in the traditional U-Net architecture. These units are composed of the amalgamated phenomenon of multi-level convolutional learning through conventional, atrous, residual, depth-wise, and point-wise convolutions which are further incorporated with target-specific attention learning and enlarged effectual receptive field size. Also, pre-processing techniques of patch-sampling, augmentation (color and morphological), stain-normalization, etc. are employed to burgeon its generalizability. To build network invariance towards digital variability, exhaustive experiments are conducted using three public datasets (Colorectal Adenocarcinoma Gland (CRAG), Gland Segmentation (GlaS) challenge, and Lung Colon-25000 (LC-25K) dataset)) and then its robustness is verified using an in-house private dataset of Hospital Colon (HosC). For the cancer classification, the proposed model achieved results of Accuracy (CRAG(95%), GlaS(97.5%), LC-25K(99.97%), HosC(99.45%)), Precision (CRAG(0.9678), GlaS(0.9768), LC-25K(1), HosC(1)), F1-score (CRAG(0.968), GlaS(0.977), LC 25K(0.9997), HosC(0.9965)), and Recall (CRAG(0.9677), GlaS(0.9767), LC-25K(0.9994), HosC(0.9931)). For the gland detection and segmentation, the proposed model achieved competitive results of F1-score (CRAG(0.924), GlaS(Test A(0.949), Test B(0.918)), LC-25K(0.916), HosC(0.959)); Object-Dice Index (CRAG(0.959), GlaS(Test A(0.956), Test B(0.909)), LC-25K(0.929), HosC(0.922)), and Object-Hausdorff Distance (CRAG(90.47), GlaS(Test A(23.17), Test B(71.53)), LC-25K(96.28), HosC(85.45)). In addition, the activation mappings for testing the interpretability of the classification decision-making process are reported by utilizing techniques of Local Interpretable Model-Agnostic Explanations, Occlusion Sensitivity, and Gradient-Weighted Class Activation Mappings. This is done to provide further evidence about the model's self-learning capability of the comparable patterns considered relevant by pathologists without any pre-requisite for annotations. These activation mapping visualization outcomes are evaluated by proficient pathologists, and they delivered these images with a class-path validation score of (CRAG(9.31), GlaS(9.25), LC-25K(9.05), and HosC(9.85)). Furthermore, the seg-path validation score of (GlaS (Test A(9.40), Test B(9.25)), CRAG(9.27), LC-25K(9.01), HosC(9.19)) given by multiple pathologists is included for the final segmented outcomes to substantiate the clinical relevance and suitability for facilitation at the clinical level. The proposed model will aid pathologists to formulate an accurate diagnosis by providing a referential opinion during the morphology assessment of histopathology images. It will reduce unintentional human error in cancer diagnosis and consequently will enhance patient survival rate.

AAMR-FCN myeloma cancer net: Adaptive and attention-based mask R-FCN for diagnosing myeloma cancer using cell microscopic images with hybrid heuristic strategy

Multiple myeloma segmentation net (MMNet): an encoder-decoder-based deep multiscale feature fusion model for multiple myeloma segmentation in magnetic resonance imaging

An Efficient Hybrid Model for Acute Myeloid Leukaemia detection using Convolutional Bi-LSTM based Recurrent Neural Network

Instance Segmentation of Multiple Myeloma Cells Using Deep-Wise Data Augmentation and Mask R-CNN

Aided Diagnosis Model Based on Deep Learning for Glioblastoma, Solitary Brain Metastases, and Primary Central Nervous System Lymphoma with Multi-Modal MRI

Diagnosing acute promyelocytic leukemia by using convolutional neural network

Refinement of ensemble strategy for acute lymphoblastic leukemia microscopic images using hybrid CNN-GRU-BiLSTM and MSVM classifier

Multi-scale Regional Attention Deeplab3+: Multiple Myeloma Plasma Cells Segmentation in Microscopic Images

CMAF-Net: a cross-modal attention fusion-based deep neural network for incomplete multi-modal brain tumor segmentation

Melanoma skin cancer detection using mask-RCNN with modified GRU model

Applying dual models on optimized LSTM with U-net segmentation for breast cancer diagnosis using mammogram images

Morphological diagnosis of hematologic malignancy using feature fusion-based deep convolutional neural network

A Novel Hybridoma Cell Segmentation Method Based on Multi-Scale Feature Fusion and Dual Attention Network

CAE-ResVGG FusionNet: A Feature Extraction Framework Integrating Convolutional Autoencoders and Transfer Learning for Immature White Blood Cells in Acute Myeloid Leukemia

MTU: A multi-tasking U-net with hybrid convolutional learning and attention modules for cancer classification and gland Segmentation in Colon Histopathological Images

Ensemble 3D CNN and U-Net-based brain tumour classification with MKKMC segmentation

A CNN-based unified framework utilizing projection loss in unison with label noise handling for multiple Myeloma cancer diagnosis

AMINN: Autoencoder-based Multiple Instance Neural Network Improves Outcome Prediction of Multifocal Liver Metastases

AMLnet, A Deep-Learning Pipeline for the Differential Diagnosis of Acute Myeloid Leukemia from Bone Marrow Smears.

Diagnosis of Malignant Lymphoma Cancer Using Hybrid Optimized Techniques Based on Dense Neural Networks

BSMM-Net: Multi-modal neural network based on bilateral symmetry for nasopharyngeal carcinoma segmentation